CoChat

Detection of cancer‐associated cachexia in lung cancer patients using whole‐body [ 18 F]FDG‐PET/CT imaging: A multi‐centre study

Ferrara, Daria, Abenavoli, Elisabetta M., Beyer, Thomas, Gruenert, Stefan, Hacker, Marcus, Hesse, Swen, Hofmann, Lukas, Pusitz, Smilla, Rullmann, Michael, Sabri, Osama, Sciagrà, Roberto, Sundar, Lalith Kumar Shiyam, Tönjes, Anke, Wirtz, Hubert, Yu, Josef, Frille, Armin · 2024 · Journal of Cachexia, Sarcopenia and Muscle
Cited by 19

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background: Cancer‐associated cachexia (CAC) is a metabolic syndrome contributing to therapy resistance and mortality in lung cancer patients (LCP). CAC is typically defined using clinical non‐imaging criteria. Given the metabolic underpinnings of CAC and the ability of [ 18 F]fluoro‐2‐deoxy‐D‐glucose (FDG)‐positron emission tomography (PET)/computer tomography (CT) to provide quantitative information on glucose turnover, we evaluate the usefulness of whole‐body (WB) PET/CT imaging, as part of the standard diagnostic workup of LCP, to provide additional information on the onset or presence of CAC. Methods: This multi‐centre study included 345 LCP who underwent WB [ 18 F]FDG‐PET/CT imaging for initial clinical staging. A weight loss grading system (WLGS) adjusted to body mass index was used to classify LCP into ‘No CAC’ (WLGS‐0/1 at baseline prior treatment and at first follow‐up: N = 158, 51F/107M), ‘Dev CAC’ (WLGS‐0/1 at baseline and WLGS‐3/4 at follow‐up: N = 90, 34F/56M), and ‘CAC’ (WLGS‐3/4 at baseline: N = 97, 31F/66M). For each CAC category, mean standardized uptake values (SUV) normalized to aorta uptake (<SUV aorta >) and CT‐defined volumes were extracted for abdominal and visceral organs, muscles, and adipose‐tissue using automated image segmentation of baseline [ 18 F]FDG‐PET/CT images. Imaging and non‐imaging parameters from laboratory tests were compared statistically. A machine‐learning (ML) model was then trained to classify LCP as ‘No CAC’, ‘Dev CAC’, and ‘CAC’ based on their imaging parameters. SHapley Additive exPlanations (SHAP) analysis was employed to identify the key factors contributing to CAC development for each patient. Results: The three CAC categories displayed multi‐organ differences in <SUV aorta >. In all target organs, <SUV aorta > was higher in the ‘CAC’ cohort compared with ‘No CAC’ ( P < 0.01), except for liver and kidneys, where <SUV aorta > in ‘CAC’ was reduced by 5%. The ‘Dev CAC’ cohort displayed a small but significant increase in <SUV aorta > of pancreas (+4%), skeletal‐muscle (+7%), subcutaneous adipose‐tissue (+11%), and visceral adipose‐tissue (+15%). In ‘CAC’ patients, a strong negative Spearman correlation (ρ = −0.8) was identified between <SUV aorta > and volumes of adipose‐tissue. The machine‐learning model identified ‘CAC’ at baseline with 81% of accuracy, highlighting <SUV aorta > of spleen, pancreas, liver, and adipose‐tissue as most relevant features. The model performance was suboptimal (54%) when classifying ‘Dev CAC’ versus ‘No CAC’. Conclusions: WB [ 18 F]FDG‐PET/CT imaging reveals groupwise differences in the multi‐organ metabolism of LCP with and without CAC, thus highlighting systemic metabolic aberrations symptomatic of cachectic patients. Based on a retrospective cohort, our ML model identified patients with CAC with good accuracy. However, its performance in patients developing CAC was suboptimal. A prospective, multi‐centre study has been initiated to address the limitations of the present retrospective analysis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcsm.13571

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 34

  1. 10.2147/CMAR.S261585 · DOI · Paper page
  2. 10.1002/jcsm.12402 · DOI · Paper page
  3. 10.1016/S1470-2045(10)70218-7 · DOI · Paper page
  4. 10.1002/jcsm.12220 · DOI
  5. 10.1038/s41571-023-00734-5 · DOI · Paper page
  6. 10.1038/s41574-018-0123-0 · DOI · Paper page
  7. 10.1200/JCO.2014.56.1894 · DOI · Paper page
  8. 10.1186/s13550-021-00834-2 · DOI
  9. 10.1200/JCO.2012.45.2722 · DOI · Paper page
  10. 10.1038/s41591-023-02232-8 · DOI
  11. Beyer T, 2000, A combined PET/CT scanner for clinical oncology, J Nucl Med, 41, 1369
  12. 10.21037/atm.2018.01.25 · DOI
  13. Nakamoto R, 2019, Close correlation in cancer patients between diffusely decreased liver uptake on FDG‐PET & cancer‐associated cachexia, J Nucl Med, 60, 217
  14. 10.1038/s41598-020-77269-7 · DOI · Paper page
  15. 10.1016/j.clinimag.2018.05.006 · DOI
  16. 10.1007/s00330‐022‐09226‐z · DOI
  17. 10.1016/j.jtho.2015.09.009 · DOI · Paper page
  18. 10.1038/sj.bjc.6606087 · DOI · Paper page
  19. 10.2967/jnumed.122.264063 · DOI · Paper page
  20. 10.1016/j.mri.2012.05.001 · DOI · Paper page
  21. 10.2307/1403797 · DOI · Paper page
  22. 10.3390/cancers15123111 · DOI
  23. 10.3322/caac.21660 · DOI · Paper page
  24. 10.3390/ijms18061216 · DOI
  25. 10.3892/ol.2021.12531 · DOI
  26. 10.1016/S0021-9258(18)83822-4 · DOI · Paper page
  27. 10.1002/cbf.3652 · DOI
  28. 10.3389/fphys.2021.625417 · DOI
  29. 10.1177/147323000703500207 · DOI
  30. 10.1007/s00259‐024‐06689‐8 · DOI
  31. 10.2967/jnumed.117.196287 · DOI · Paper page
  32. 10.1016/j.amjsurg.2011.06.053 · DOI
  33. 10.1016/S0261-5614(03)00098-0 · DOI · Paper page
  34. Gutschmayer S, 2022, Annual Congress of the European Association of Nuclear Medicine October 15–19, 2022, 225

Cited by

See all 19

Metadata

Authors
Ferrara, D., Abenavoli, E. M., Beyer, T., Gruenert, S., Hacker, M., Hesse, S., Hofmann, L., Pusitz, S., Rullmann, M., Sabri, O., Sciagrà, R., Sundar, L. K. S., Tönjes, A., Wirtz, H., Yu, J., & Frille, A.
Affiliations
  • QIMP Team Medical University of Vienna Vienna Austria
  • Division of Nuclear Medicine Azienda Ospedaliero Universitaria Careggi Florence Italy
  • Division of Nuclear Medicine Medical University of Vienna Vienna Austria
  • Department of Nuclear Medicine University Hospital Leipzig Leipzig Germany
  • Department of Endocrinology University Hospital Leipzig Leipzig Germany
  • Department of Respiratory Medicine University Hospital Leipzig Leipzig Germany
Venue
Journal of Cachexia, Sarcopenia and Muscle
Publisher
Wiley
Published
2024-08-27
Volume
15
Issue
6
Pages
2375-2386
ISSN
  • 2190-5991
  • 2190-6009
Cited by
19
References
6
Language
en
Funders
  • Directorate-General XII, Science, Research, and Development (779282)
  • Austrian Science Fund
  • Innovationsfonden
  • Regione Toscana
  • Novartis Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Detection of cancer‐associated cachexia in lung cancer patients using whole‐body [ 18 F]FDG‐PET/CT imaging: A multi‐centre study. https://app.cochat.ai/papers/10.1002/jcsm.13571
The paper
Ferrara, D., Abenavoli, E. M., Beyer, T., Gruenert, S., Hacker, M., Hesse, S., Hofmann, L., Pusitz, S., Rullmann, M., Sabri, O., Sciagrà, R., Sundar, L. K. S., Tönjes, A., Wirtz, H., Yu, J., & Frille, A. (2024). Detection of cancer‐associated cachexia in lung cancer patients using whole‐body [ 18 F]FDG‐PET/CT imaging: A multi‐centre study. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13571

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.